Evidence map›Paper›PMID 35171454›Full record

ArticleInfection2022

The impact of COVID-19 pandemic control on vaccine-preventable invasive bacterial diseases in Piedmont (Italy).

Marco Peradotto, A Bondi, D Lombardi, P Bottino, E Zanotto, A M Barbui, R Cavallo

Open access · bronzeAbstract read
In one paragraph

Article in Infection, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.2field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Marco PeradottoMicrobiology and Virology Unit, University Hospital Città della Salute e della Scienza di Torino, C.so Bramante 88/90, 10126, Torino, Italy. marcobio92@gmail.com.ORCID http://orcid.org/0000-0001-6236-1010
A BondiMicrobiology and Virology Unit, University Hospital Città della Salute e della Scienza di Torino, C.so Bramante 88/90, 10126, Torino, Italy.
D LombardiServizio di Riferimento Regionale di Epidemiologia per la Sorveglianza, la Prevenzione e il Controllo delle Malattie Infettive (SEREMI), Azienda Sanitaria Locale Alessandria, Alessandria, Italy.
P BottinoMicrobiology and Virology Unit, University Hospital Città della Salute e della Scienza di Torino, C.so Bramante 88/90, 10126, Torino, Italy.
E ZanottoMicrobiology and Virology Unit, University Hospital Città della Salute e della Scienza di Torino, C.so Bramante 88/90, 10126, Torino, Italy.
A M BarbuiMicrobiology and Virology Unit, University Hospital Città della Salute e della Scienza di Torino, C.so Bramante 88/90, 10126, Torino, Italy.
R CavalloMicrobiology and Virology Unit, University Hospital Città della Salute e della Scienza di Torino, C.so Bramante 88/90, 10126, Torino, Italy.
Azienda Ospedaliera Citta' della Salute e della Scienza di Torino · ITAzienda Sanitaria Locale Alessandria · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeThe impact of SARS-CoV-2 pandemic on other pathogens is largely unknown. We aimed to compare the prevalence of vaccine-preventable invasive bacterial infections before and during the pandemic in Piedmont (Italy).

methodsWe defined the monthly incidence of S. pneumoniae, H. influenzae and N. meningitides-invasive diseases from January 2010 to June 2021. Then, we compared the mean monthly cases during the previous 5 years (2015-2019) and the monthly cases in 2020 or 2021.

resultsWe found significant reductions for invasive pneumococcal diseases (IPDs) in adults and H. influenzae-invasive diseases in 2020 and 2021 in comparison to the previous years, but not for invasive meningococcal diseases and IPDs in children.

conclusionsFurther data are needed to confirm these findings and define possible post-pandemic evolutions in the epidemiology of vaccine-preventable invasive bacterial diseases.

Indexed as

Bacterial InfectionsCOVID-19Pneumococcal InfectionsVaccinesAdultBacteriaChildHaemophilus influenzaeHumansIncidenceInfantPandemicsSARS-CoV-2Streptococcus pneumoniaeVaccinesBacterial-invasive infectionsCOVID-19 pandemicSocial distancingVaccine-preventable diseases

Identifiers

PMID35171454
PMCPMC8852962
OpenAlexW4213238417

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.